ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15I14597
Home | Market Reports | Science
Global mRNA Drug Market Research Report 2023
BUY CHAPTERS

Global mRNA Drug Market Research Report 2025

Code: QYRE-Auto-15I14597
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Moderna, Inc
Pfizer Inc
Zydus Cadila
Fosun Pharma
CureVac
BioNTech
Astrazeneca plc
Janssen
Sri Lankan Microorganisms

mRNA Drug Market Size

The global market for mRNA Drug was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 600 million by 2031, growing at a CAGR of 5.0% during the forecast period.

mRNA Drug Market

mRNA Drug Market

Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for mRNA Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Drug.
The mRNA Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of mRNA Drug Market Report

Report Metric Details
Report Name mRNA Drug Market
Accounted market size in year US$ 428 million
Forecasted market size in 2031 US$ 600 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca, Janssen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of mRNA Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of mRNA Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is mRNA Drug Market growing?

Ans: The mRNA Drug Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the mRNA Drug Market size in 2031?

Ans: The mRNA Drug Market size in 2031 will be US$ 600 million.

Who are the main players in the mRNA Drug Market report?

Ans: The main players in the mRNA Drug Market are Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca, Janssen

What are the Application segmentation covered in the mRNA Drug Market report?

Ans: The Applications covered in the mRNA Drug Market report are Hospital, Clinic

What are the Type segmentation covered in the mRNA Drug Market report?

Ans: The Types covered in the mRNA Drug Market report are Preventive Vaccines, Therapeutic Vaccine, Therapeutic Drugs

Recommended Reports

Gene and Cell Therapy

Drug Delivery Systems

Pharmaceutical Disease Treatments

1 mRNA Drug Market Overview
1.1 Product Definition
1.2 mRNA Drug by Type
1.2.1 Global mRNA Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Preventive Vaccines
1.2.3 Therapeutic Vaccine
1.2.4 Therapeutic Drugs
1.3 mRNA Drug by Application
1.3.1 Global mRNA Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global mRNA Drug Market Size Estimates and Forecasts
1.4.1 Global mRNA Drug Revenue 2020-2031
1.4.2 Global mRNA Drug Sales 2020-2031
1.4.3 Global mRNA Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 mRNA Drug Market Competition by Manufacturers
2.1 Global mRNA Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global mRNA Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global mRNA Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of mRNA Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Drug, Product Type & Application
2.7 Global Key Manufacturers of mRNA Drug, Date of Enter into This Industry
2.8 Global mRNA Drug Market Competitive Situation and Trends
2.8.1 Global mRNA Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest mRNA Drug Players Market Share by Revenue
2.8.3 Global mRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Drug Market Scenario by Region
3.1 Global mRNA Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global mRNA Drug Sales by Region: 2020-2031
3.2.1 Global mRNA Drug Sales by Region: 2020-2025
3.2.2 Global mRNA Drug Sales by Region: 2026-2031
3.3 Global mRNA Drug Revenue by Region: 2020-2031
3.3.1 Global mRNA Drug Revenue by Region: 2020-2025
3.3.2 Global mRNA Drug Revenue by Region: 2026-2031
3.4 North America mRNA Drug Market Facts & Figures by Country
3.4.1 North America mRNA Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America mRNA Drug Sales by Country (2020-2031)
3.4.3 North America mRNA Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Drug Market Facts & Figures by Country
3.5.1 Europe mRNA Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe mRNA Drug Sales by Country (2020-2031)
3.5.3 Europe mRNA Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Drug Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific mRNA Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific mRNA Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Drug Market Facts & Figures by Country
3.7.1 Latin America mRNA Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America mRNA Drug Sales by Country (2020-2031)
3.7.3 Latin America mRNA Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa mRNA Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa mRNA Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa mRNA Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global mRNA Drug Sales by Type (2020-2031)
4.1.1 Global mRNA Drug Sales by Type (2020-2025)
4.1.2 Global mRNA Drug Sales by Type (2026-2031)
4.1.3 Global mRNA Drug Sales Market Share by Type (2020-2031)
4.2 Global mRNA Drug Revenue by Type (2020-2031)
4.2.1 Global mRNA Drug Revenue by Type (2020-2025)
4.2.2 Global mRNA Drug Revenue by Type (2026-2031)
4.2.3 Global mRNA Drug Revenue Market Share by Type (2020-2031)
4.3 Global mRNA Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global mRNA Drug Sales by Application (2020-2031)
5.1.1 Global mRNA Drug Sales by Application (2020-2025)
5.1.2 Global mRNA Drug Sales by Application (2026-2031)
5.1.3 Global mRNA Drug Sales Market Share by Application (2020-2031)
5.2 Global mRNA Drug Revenue by Application (2020-2031)
5.2.1 Global mRNA Drug Revenue by Application (2020-2025)
5.2.2 Global mRNA Drug Revenue by Application (2026-2031)
5.2.3 Global mRNA Drug Revenue Market Share by Application (2020-2031)
5.3 Global mRNA Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Company Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Moderna mRNA Drug Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer mRNA Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Company Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zydus Cadila mRNA Drug Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Fosun Pharma
6.4.1 Fosun Pharma Company Information
6.4.2 Fosun Pharma Description and Business Overview
6.4.3 Fosun Pharma mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Fosun Pharma mRNA Drug Product Portfolio
6.4.5 Fosun Pharma Recent Developments/Updates
6.5 CureVAC
6.5.1 CureVAC Company Information
6.5.2 CureVAC Description and Business Overview
6.5.3 CureVAC mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CureVAC mRNA Drug Product Portfolio
6.5.5 CureVAC Recent Developments/Updates
6.6 Sri Lankan Microorganisms
6.6.1 Sri Lankan Microorganisms Company Information
6.6.2 Sri Lankan Microorganisms Description and Business Overview
6.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
6.6.5 Sri Lankan Microorganisms Recent Developments/Updates
6.7 BioNtech
6.7.1 BioNtech Company Information
6.7.2 BioNtech Description and Business Overview
6.7.3 BioNtech mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BioNtech mRNA Drug Product Portfolio
6.7.5 BioNtech Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca mRNA Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Company Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen mRNA Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Janssen mRNA Drug Product Portfolio
6.9.5 Janssen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Drug Industry Chain Analysis
7.2 mRNA Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Drug Production Mode & Process Analysis
7.4 mRNA Drug Sales and Marketing
7.4.1 mRNA Drug Sales Channels
7.4.2 mRNA Drug Distributors
7.5 mRNA Drug Customer Analysis
8 mRNA Drug Market Dynamics
8.1 mRNA Drug Industry Trends
8.2 mRNA Drug Market Drivers
8.3 mRNA Drug Market Challenges
8.4 mRNA Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Moderna, Inc
Pfizer Inc
Zydus Cadila
Fosun Pharma
CureVac
BioNTech
Astrazeneca plc
Janssen
Sri Lankan Microorganisms
List of Tables
 Table 1. Global mRNA Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global mRNA Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global mRNA Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global mRNA Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global mRNA Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global mRNA Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global mRNA Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market mRNA Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of mRNA Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of mRNA Drug, Product Type & Application
 Table 12. Global Key Manufacturers of mRNA Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global mRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global mRNA Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global mRNA Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global mRNA Drug Sales Market Share by Region (2020-2025)
 Table 19. Global mRNA Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global mRNA Drug Sales Market Share by Region (2026-2031)
 Table 21. Global mRNA Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global mRNA Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global mRNA Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global mRNA Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America mRNA Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America mRNA Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America mRNA Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America mRNA Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America mRNA Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe mRNA Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe mRNA Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe mRNA Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe mRNA Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe mRNA Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific mRNA Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific mRNA Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific mRNA Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific mRNA Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific mRNA Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America mRNA Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America mRNA Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America mRNA Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America mRNA Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America mRNA Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa mRNA Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa mRNA Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa mRNA Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa mRNA Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa mRNA Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global mRNA Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global mRNA Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global mRNA Drug Sales Market Share by Type (2020-2025)
 Table 53. Global mRNA Drug Sales Market Share by Type (2026-2031)
 Table 54. Global mRNA Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global mRNA Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global mRNA Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global mRNA Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global mRNA Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global mRNA Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global mRNA Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global mRNA Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global mRNA Drug Sales Market Share by Application (2020-2025)
 Table 63. Global mRNA Drug Sales Market Share by Application (2026-2031)
 Table 64. Global mRNA Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global mRNA Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global mRNA Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global mRNA Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global mRNA Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global mRNA Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Moderna Company Information
 Table 71. Moderna Description and Business Overview
 Table 72. Moderna mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Moderna mRNA Drug Product
 Table 74. Moderna Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer mRNA Drug Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Zydus Cadila Company Information
 Table 81. Zydus Cadila Description and Business Overview
 Table 82. Zydus Cadila mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zydus Cadila mRNA Drug Product
 Table 84. Zydus Cadila Recent Developments/Updates
 Table 85. Fosun Pharma Company Information
 Table 86. Fosun Pharma Description and Business Overview
 Table 87. Fosun Pharma mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Fosun Pharma mRNA Drug Product
 Table 89. Fosun Pharma Recent Developments/Updates
 Table 90. CureVAC Company Information
 Table 91. CureVAC Description and Business Overview
 Table 92. CureVAC mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CureVAC mRNA Drug Product
 Table 94. CureVAC Recent Developments/Updates
 Table 95. Sri Lankan Microorganisms Company Information
 Table 96. Sri Lankan Microorganisms Description and Business Overview
 Table 97. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sri Lankan Microorganisms mRNA Drug Product
 Table 99. Sri Lankan Microorganisms Recent Developments/Updates
 Table 100. BioNtech Company Information
 Table 101. BioNtech Description and Business Overview
 Table 102. BioNtech mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BioNtech mRNA Drug Product
 Table 104. BioNtech Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AstraZeneca mRNA Drug Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Janssen Company Information
 Table 111. Janssen Description and Business Overview
 Table 112. Janssen mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Janssen mRNA Drug Product
 Table 114. Janssen Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. mRNA Drug Distributors List
 Table 118. mRNA Drug Customers List
 Table 119. mRNA Drug Market Trends
 Table 120. mRNA Drug Market Drivers
 Table 121. mRNA Drug Market Challenges
 Table 122. mRNA Drug Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of mRNA Drug
 Figure 2. Global mRNA Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global mRNA Drug Market Share by Type: 2024 & 2031
 Figure 4. Preventive Vaccines Product Picture
 Figure 5. Therapeutic Vaccine Product Picture
 Figure 6. Therapeutic Drugs Product Picture
 Figure 7. Global mRNA Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global mRNA Drug Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global mRNA Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global mRNA Drug Market Size (2020-2031) & (US$ Million)
 Figure 13. Global mRNA Drug Sales (2020-2031) & (K Units)
 Figure 14. Global mRNA Drug Average Price (US$/Unit) & (2020-2031)
 Figure 15. mRNA Drug Report Years Considered
 Figure 16. mRNA Drug Sales Share by Manufacturers in 2024
 Figure 17. Global mRNA Drug Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest mRNA Drug Players: Market Share by Revenue in mRNA Drug in 2024
 Figure 19. mRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global mRNA Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America mRNA Drug Sales Market Share by Country (2020-2031)
 Figure 22. North America mRNA Drug Revenue Market Share by Country (2020-2031)
 Figure 23. United States mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe mRNA Drug Sales Market Share by Country (2020-2031)
 Figure 26. Europe mRNA Drug Revenue Market Share by Country (2020-2031)
 Figure 27. Germany mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific mRNA Drug Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific mRNA Drug Revenue Market Share by Region (2020-2031)
 Figure 34. China mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America mRNA Drug Sales Market Share by Country (2020-2031)
 Figure 42. Latin America mRNA Drug Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa mRNA Drug Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa mRNA Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE mRNA Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of mRNA Drug by Type (2020-2031)
 Figure 52. Global Revenue Market Share of mRNA Drug by Type (2020-2031)
 Figure 53. Global mRNA Drug Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of mRNA Drug by Application (2020-2031)
 Figure 55. Global Revenue Market Share of mRNA Drug by Application (2020-2031)
 Figure 56. Global mRNA Drug Price (US$/Unit) by Application (2020-2031)
 Figure 57. mRNA Drug Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global mRNA Vaccines Therapeutics Market Research Report 2024
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Therapy Market Research Report 2024
Global mRNA Synthesis Manufacturing Market Research Report 2024
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
mRNA Transcriptome Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Vaccines Market Insights Forecast to 2030
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Treatment Market Research Report 2024
mRNA COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Vaccine Raw Materials Market Research Report 2024
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global mRNA Vaccine Drugs Development Services Market Research Report 2024
Global Livestock mRNA Vaccines Market Research Report 2025
Global IVT mRNA Synthesis Service Market Research Report 2025
Global RNA Therapeutics Market Research Report 2024
Global Veterinary mRNA Vaccines Market Research Report 2025
Global Nucleic Acid Medicine Market Research Report 2025
Global Self amplifying RNA saRNA Drugs Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions